Arthneeti
Sale is live|00:00:00
Himadri Speciality Chemical LtdQ1 FY26

Himadri Speciality Chemical Ltd Q1 FY26 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: 678P/E: 40.0Market Cap: ₹30.1K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • FY27 expected to show both top-line (revenue) and bottom-line (PAT) growth after a period of minimal top-line growth.
  • New capacities coming online, including Birla Tyres and expanded carbon black capacity, will drive top-line growth.
  • Commitment to doubling PAT to INR 1,100+ crores by FY28 from INR 555 crores in FY25.
  • Top-line growth rate guidance for FY27 not explicitly quantified, but growth is anticipated driven by new product additions and capacity expansions.
  • Expansion plan includes scaling cathode capacity from 2,000 MTPA initial to 40,000 MTPA by FY29, with further scale-up planned.
  • Birla Tyres business expects to grow from INR 187 crores in FY26 to approx INR 3,000 crores in next 4 years.
  • New advanced battery material capacities (anode and cathode) expected to contribute to revenue growth once commercial scale plants come online.

Margin guidance

Category 3
  • Himadri expects strong top-line and bottom-line growth starting FY27, driven by new capacities and value-added products.
  • PAT is targeted to double from INR 555 crores in FY25 to INR 1,100+ crores by FY28.
  • Sustainable EBITDA margins of around 20% are anticipated, with long-term margin expansion supported by operational efficiencies and yield improvements.
  • The company projects steady margin improvement from existing levels beyond FY27 due to new capacity additions.
  • Birla Tyres segment revenue is expected to scale from INR 187 crores in FY26 to around INR 3,000 crores in four years.
  • Future expansion plans for anode and cathode materials are in progress, poised to add significant revenue and growth.
  • Overall, earnings growth is expected to be robust with focus on PAT rather than EBITDA as key performance metric.

3 more insights locked — sign up free to unlock

Fundraise plans

  • No current or immediate new fundraising through debt or equity has been announced.
  • For future expansion, the company plans to primarily use internal accruals for all expansion needs.
  • If debt is taken for future projects, it will be a very significantly low portion, mainly to cover timing gaps.
  • The company prefers to avoid heavy debt and focuses on disciplined capital deployment.
  • Any major new capex, particularly for the anode business, will be announced once finalized.
  • Existing bank limits are utilized efficiently, taking loans at lower rates and placing funds at higher rates to generate income.
  • Overall, no change in the announced capex plans as of now.

Order book

  • The company has signed certain MOUs or LOIs related to Phase 1 capacity, but due to NDA, details including binding agreements with Indian or global cell manufacturers for LFP supply cannot be disclosed currently.
  • The order book or contracting of Phase 1 capacity depends on product approvals, which will affect these LOIs.
  • No explicit quantification of current or expected order book/pending orders was shared in the transcript.
  • Anurag Choudhary emphasized that disclosures will be made at the appropriate time once approvals and agreements materialize.

Capex plans

Yes
  • Phase 1 cathode capacity: 40,000 MTPA planned, with initial 2,000 tons to be commissioned soon; full 40,000 tons expected by FY29.
  • Capex for Phase 1 cathode facility: INR 1,125 crores.
  • Anode capacity: 200 metric tons plant commissioned to commercialize R&D; large-scale commercial capacity capex to be announced soon.
  • No new capex beyond already announced plans; anode capex details will be disclosed after finalization.
  • Future expansions primarily to be funded through internal accruals; minimal or low debt expected, mostly for timing gaps.
  • Renewable energy will be consumed via long-term contracts rather than direct investment for cathode plant.
  • Birla Tyres revival with expected top line of INR 3,000 crores in next 4 years; no immediate new capex disclosed.

How does Himadri Speciality Chemical Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature
1Himadri Speciality Chemical Ltd
Rev 3Mar 3

See full Chemicals & Petrochemicals sector rankings

Want more stocks like Himadri Speciality Chemical Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio